← All patents

US20190071505A1

Compositions and methods for activation of nk cells killing of prostate cancer …

University of North Texas Health Science Center

Abstract

Certain embodiments are directed to methods of treating LLT1 expressing cancer by administering to a subject having an LLT1 expressing cancer an LLT1 inhibitor.

University
University of North Texas Health Science Center
Assignee
University Of North Texas Health Science Center
Inventor
Purunelloor A. Mathew
Priority date
September 07, 2017
Filing date
September 07, 2018
Publication date
March 07, 2019
Language
en
Metadata fetched
August 28, 2026 19:12